Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1970 1
1971 1
1973 2
1974 4
1975 3
1976 5
1977 5
1978 8
1979 3
1980 2
1981 2
1982 6
1983 8
1984 2
1985 2
1986 6
1987 3
1988 5
1989 5
1990 4
1991 11
1992 16
1993 8
1994 9
1995 13
1996 7
1997 13
1998 19
1999 11
2000 12
2001 14
2002 14
2003 15
2004 11
2005 15
2006 16
2007 19
2008 53
2009 38
2010 25
2011 17
2012 21
2013 29
2014 37
2015 24
2016 15
2017 17
2018 10
2019 12
2020 15
2021 20
2022 19
2023 13
2024 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

641 results

Results by year

Filters applied: . Clear all
Page 1
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial.
Strober B, Thaçi D, Sofen H, Kircik L, Gordon KB, Foley P, Rich P, Paul C, Bagel J, Colston E, Throup J, Kundu S, Sekaran C, Linaberry M, Banerjee S, Papp KA. Strober B, et al. Among authors: rich p. J Am Acad Dermatol. 2023 Jan;88(1):40-51. doi: 10.1016/j.jaad.2022.08.061. Epub 2022 Sep 14. J Am Acad Dermatol. 2023. PMID: 36115523 Free article. Clinical Trial.
An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis.
Bissonnette R, Pinter A, Ferris LK, Gerdes S, Rich P, Vender R, Miller M, Shen YK, Kannan A, Li S, DeKlotz C, Papp K. Bissonnette R, et al. Among authors: rich p. N Engl J Med. 2024 Feb 8;390(6):510-521. doi: 10.1056/NEJMoa2308713. N Engl J Med. 2024. PMID: 38324484 Clinical Trial.
Isolated nail lichen planus: An expert consensus on treatment of the classical form.
Iorizzo M, Tosti A, Starace M, Baran R, Daniel CR 3rd, Di Chiacchio N, Goettmann S, Grover C, Haneke E, Lipner SR, Rich P, Richert B, Rigopoulos D, Rubin AI, Zaiac M, Piraccini BM. Iorizzo M, et al. Among authors: rich p. J Am Acad Dermatol. 2020 Dec;83(6):1717-1723. doi: 10.1016/j.jaad.2020.02.056. Epub 2020 Feb 26. J Am Acad Dermatol. 2020. PMID: 32112995 Review.
Nail Tumors.
Hare AQ, Rich P. Hare AQ, et al. Among authors: rich p. Dermatol Clin. 2021 Apr;39(2):281-292. doi: 10.1016/j.det.2020.12.007. Dermatol Clin. 2021. PMID: 33745640 Review.
Nail psoriasis.
Manhart R, Rich P. Manhart R, et al. Among authors: rich p. Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S7-13. Epub 2015 Oct 15. Clin Exp Rheumatol. 2015. PMID: 26472140 Review.
Melanonychia.
Jefferson J, Rich P. Jefferson J, et al. Among authors: rich p. Dermatol Res Pract. 2012;2012:952186. doi: 10.1155/2012/952186. Epub 2012 Jun 27. Dermatol Res Pract. 2012. PMID: 22792094 Free PMC article.
Nail cosmetics.
Rich P. Rich P. Dermatol Clin. 2006 Jul;24(3):393-9. doi: 10.1016/j.det.2006.03.011. Dermatol Clin. 2006. PMID: 16798439 Review.
641 results